(NASDAQ: ACCD) Accolade's forecast annual revenue growth rate of 21.76% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.
Accolade's revenue in 2024 is $388,486,000.On average, 8 Wall Street analysts forecast ACCD's revenue for 2025 to be $38,222,018,554, with the lowest ACCD revenue forecast at $37,503,985,592, and the highest ACCD revenue forecast at $38,665,099,697. On average, 7 Wall Street analysts forecast ACCD's revenue for 2026 to be $45,371,539,952, with the lowest ACCD revenue forecast at $43,510,815,895, and the highest ACCD revenue forecast at $46,645,823,978.
In 2027, ACCD is forecast to generate $54,924,180,509 in revenue, with the lowest revenue forecast at $54,121,850,662 and the highest revenue forecast at $55,834,106,929.